Combinatorial Optimization of Cystine-Knot Peptides towards High-Affinity Inhibitors of Human Matriptase-1

被引:47
|
作者
Glotzbach, Bernhard [1 ]
Reinwarth, Michael [1 ]
Weber, Niklas [1 ]
Fabritz, Sebastian [2 ]
Tomaszowski, Michael [1 ]
Fittler, Heiko [1 ]
Christmann, Andreas [1 ]
Avrutina, Olga [1 ]
Kolmar, Harald [1 ]
机构
[1] Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany
[2] AB SCIEX Germany GmbH, Darmstadt, Germany
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
ELATERIUM TRYPSIN-INHIBITOR; FACTOR ACTIVATOR INHIBITOR-1; SERINE-PROTEASE MATRIPTASE; YEAST SURFACE DISPLAY; MOMORDICA-COCHINCHINENSIS; ALPHA(V)BETA(3) INTEGRIN; PLASMINOGEN ACTIVATION; ENVELOPE GLYCOPROTEIN; PLATELET-AGGREGATION; SELECTIVE INHIBITORS;
D O I
10.1371/journal.pone.0076956
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cystine-knot miniproteins define a class of bioactive molecules with several thousand natural members. Their eponymous motif comprises a rigid structured core formed by six disulfide-connected cysteine residues, which accounts for its exceptional stability towards thermic or proteolytic degradation. Since they display a remarkable sequence tolerance within their disulfide-connected loops, these molecules are considered promising frameworks for peptide-based pharmaceuticals. Natural open-chain cystine-knot trypsin inhibitors of the MCoTI (Momordica cochinchinensis trypsin inhibitor) and SOTI (Spinacia oleracea trypsin inhibitor) families served as starting points for the generation of inhibitors of matriptase-1, a type II transmembrane serine protease with possible clinical relevance in cancer and arthritic therapy. Yeast surface-displayed libraries of miniproteins were used to select unique and potent matriptase-1 inhibitors. To this end, a knowledge-based library design was applied that makes use of detailed information on binding and folding behavior of cystine-knot peptides. Five inhibitor variants, four of the MCoTI family and one of the SOTI family, were identified, chemically synthesized and oxidatively folded towards the bioactive conformation. Enzyme assays revealed inhibition constants in the low nanomolar range for all candidates. One subnanomolar binder (K-i = 0.83 nM) with an inverted selectivity towards trypsin and matriptase-1 was identified.
引用
收藏
页数:10
相关论文
共 12 条
  • [1] Directed evolution identifies high-affinity cystine-knot peptide agonists and antagonists of Wnt/β-catenin signaling
    Hansen, Simon
    Zhang, Yingnan
    Hwang, Sunhee
    Nabhan, Ahmad
    Li, Wanqing
    Fuhrmann, Jakob
    Kschonsak, Yvonne
    Zhou, Lijuan
    Nile, Aaron H.
    Gao, Xinxin
    Piskol, Robert
    de Sousa e Melo, Felipe
    de Sauvage, Frederic J.
    Hannoush, Rami N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (46)
  • [2] Combinatorial tuning of peptidic drug candidates: high-affinity matriptase inhibitors through incremental structure-guided optimization
    Fittler, Heiko
    Avrutina, Olga
    Glotzbach, Bernhard
    Empting, Martin
    Kolmar, Harald
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (11) : 1848 - 1857
  • [3] Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists
    Krause, Sebastian
    Schmoldt, Hans-Ulrich
    Wentzel, Alexander
    Ballmaier, Matthias
    Friedrich, Karlheinz
    Kolmar, Harald
    FEBS JOURNAL, 2007, 274 (01) : 86 - 95
  • [4] Potent Knottin and SFTI-based Peptide Inhibitors of Human Matriptase-1 Obtained by Rational Design and Combinatorial Library screening
    Kolmar, Harald
    Empting, Martin
    Glotzbach, Bernhard
    Reinwarth, Michael
    Fittler, Heiko
    Avrutina, Olga
    BIOPOLYMERS, 2013, 100 (03) : 298 - 298
  • [5] Iterative optimization of high-affinity protease inhibitors using phage display .1. Plasmin
    Markland, W
    Ley, AC
    Lee, SW
    Ladner, RC
    BIOCHEMISTRY, 1996, 35 (24) : 8045 - 8057
  • [6] HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    SCHNEIDER, DJ
    FEIGON, J
    HOSTOMSKY, Z
    GOLD, L
    BIOCHEMISTRY, 1995, 34 (29) : 9599 - 9610
  • [7] In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1
    Tumdam, R.
    Kumar, A.
    Subbarao, N.
    Balaji, B. S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2018, 29 (12) : 975 - 996
  • [8] Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1
    Damaraju, Vijaya L.
    Smith, Kyla M.
    Mowles, Delores
    Nowak, Ireneusz
    Karpinski, Edward
    Young, James D.
    Robins, Morris J.
    Cass, Carol E.
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (01) : 82 - 90
  • [9] Isolation of high-affinity human IgE and IgG antibodies recognising Bet v 1 and Humicola lanuginosa lipase from combinatorial phage libraries
    Jakobsen, CG
    Bodtger, U
    Kristensen, P
    Poulsen, LK
    Roggen, EL
    MOLECULAR IMMUNOLOGY, 2004, 41 (10) : 941 - 953
  • [10] Stable Extended Human Immunodeficiency Virus Type 1 gp41 Coiled Coil as an Effective Target in an Assay for High-Affinity Fusion Inhibitors
    Cai, Lifeng
    Balogh, Edina
    Gochin, Miriam
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) : 2444 - 2449